OBJECTIVE: To assess the effect of age on outcomes following thoracic aortic endografting. SUMMARY BACKGROUND DATA: Endograft therapy for thoracic aortic disease is rapidly evolving. This therapy is less invasive, and elderly patients with significant medical comorbidities are more frequently referred for endografting. We hypothesized that elderly patients over the age of 75 have worse outcomes after thoracic endografting than patients under the age of 75. METHODS: We retrospectively reviewed the charts of the first 42 patients who underwent endografting for thoracic aortic pathology. Charts were reviewed for demographics, comorbid conditions, perioperative complications and death, endoleaks, and results at 3, 6, and 12 months. Preexisting medical conditions were also evaluated to determine if any patient characteristics were associated with adverse outcomes. Perioperative morbidity included cardiac, pulmonary, renal, hemorrhagic, and neurologic (stroke and spinal cord injury) complications. RESULTS: Twenty-four patients were under the age of 75, and 18 patients were 75 or older. Baseline demographics and comorbidities were similar between the 2 groups. There were no differences in operative time, length of stay, perioperative mortality, or the incidence of significant complications between the 2 age groups. Gender, however, was associated with a statistically significant difference between the occurrence of complications, with more women experiencing complications than men (P = 0.026, relative risk = 2.36). One patient (age >75 years) in the entire cohort of 42 (2.4%) suffered a spinal cord injury. At 3 months, endoleaks were more common in the older age group (P = 0.059). CONCLUSION: Endograft therapy for thoracic aortic disease can be performed safely in elderly patients with no significant increase in perioperative morbidity or mortality compared with younger patients. Female gender is associated with a higher likelihood of perioperative complications, regardless of age. The overall incidence of spinal cord injury is very low. Endograft therapy, when anatomically possible, is the treatment of choice for thoracic aortic disease in elderly patients.
OBJECTIVE: To assess the effect of age on outcomes following thoracic aortic endografting. SUMMARY BACKGROUND DATA: Endograft therapy for thoracic aortic disease is rapidly evolving. This therapy is less invasive, and elderly patients with significant medical comorbidities are more frequently referred for endografting. We hypothesized that elderly patients over the age of 75 have worse outcomes after thoracic endografting than patients under the age of 75. METHODS: We retrospectively reviewed the charts of the first 42 patients who underwent endografting for thoracic aortic pathology. Charts were reviewed for demographics, comorbid conditions, perioperative complications and death, endoleaks, and results at 3, 6, and 12 months. Preexisting medical conditions were also evaluated to determine if any patient characteristics were associated with adverse outcomes. Perioperative morbidity included cardiac, pulmonary, renal, hemorrhagic, and neurologic (stroke and spinal cord injury) complications. RESULTS: Twenty-four patients were under the age of 75, and 18 patients were 75 or older. Baseline demographics and comorbidities were similar between the 2 groups. There were no differences in operative time, length of stay, perioperative mortality, or the incidence of significant complications between the 2 age groups. Gender, however, was associated with a statistically significant difference between the occurrence of complications, with more women experiencing complications than men (P = 0.026, relative risk = 2.36). One patient (age >75 years) in the entire cohort of 42 (2.4%) suffered a spinal cord injury. At 3 months, endoleaks were more common in the older age group (P = 0.059). CONCLUSION: Endograft therapy for thoracic aortic disease can be performed safely in elderly patients with no significant increase in perioperative morbidity or mortality compared with younger patients. Female gender is associated with a higher likelihood of perioperative complications, regardless of age. The overall incidence of spinal cord injury is very low. Endograft therapy, when anatomically possible, is the treatment of choice for thoracic aortic disease in elderly patients.
Authors: J S Coselli; S A LeMaire; C C Miller; Z C Schmittling; C Köksoy; J Pagan; P E Curling Journal: Ann Thorac Surg Date: 2000-02 Impact factor: 4.330
Authors: Y Okita; M Ando; K Minatoya; O Tagusari; S Kitamura; N Nakajjma; S Takamoto Journal: Eur J Cardiothorac Surg Date: 1999-09 Impact factor: 4.191
Authors: Robin H Heijmen; Ivo G Deblier; Frans L Moll; Karl M Dossche; Jos C van den Berg; Tim Th Overtoom; Sjef M Ernst; Marc A Schepens Journal: Eur J Cardiothorac Surg Date: 2002-01 Impact factor: 4.191
Authors: Joseph S Coselli; Scott A LeMaire; Lon D Conklin; Cüneyt Köksoy; Zachary C Schmittling Journal: Ann Thorac Surg Date: 2002-04 Impact factor: 4.330
Authors: Ryan R Davies; Lee J Goldstein; Michael A Coady; Shawn L Tittle; John A Rizzo; Gary S Kopf; John A Elefteriades Journal: Ann Thorac Surg Date: 2002-01 Impact factor: 4.330
Authors: Michael Brandt; Katrin Hussel; Knut P Walluscheck; Stefan Müller-Hülsbeck; Thomas Jahnke; Aziz Rahimi; Jochen Cremer Journal: J Endovasc Ther Date: 2004-10 Impact factor: 3.487
Authors: Charles C Miller; Eyal E Porat; Anthony L Estrera; Anders N Vinnerkvist; Tam T T Huynh; Hazim J Safi Journal: Eur J Cardiothorac Surg Date: 2003-06 Impact factor: 4.191
Authors: Mario Castaño; Javier Gualis; Jose M Martínez-Comendador; Elio Martín; Pasquale Maiorano; Laura Castillo Journal: J Thorac Dis Date: 2017-05 Impact factor: 2.895